Observations on the effects of aerosolized albuterol in acute asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 2, 1997, Pages 454-458

  Strauss, Louise ^b   Hejal, Rana ^b   Galan, Gayle ^b   Dixon, Lisa ^b   McFadden Jr , E R ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CLINICAL FEATURE; COST BENEFIT ANALYSIS; CYANOSIS; DIAPHORESIS; DOSE RESPONSE; DYSPNEA; EXPIRATORY FLOW; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEBULIZATION; PATIENT CARE; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; SYMPTOMATOLOGY; TACHYPNEA; TREATMENT PLANNING; WHEEZING;

EID: 0031058660     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.2.9032178     Document Type: Article

References (27)

1. Hargreave, F. E., J. Dolovich, and M. T. Newhouse. 1990. The assessment and treatment of asthma: a conference report. J. Allergy Clin. Immunol. 85:1098-1111.
2. National Asthma Education Program, Expert Panel Report. 1991. Executive summary: guidelines for the diagnosis and management of asthma. U.S. Department of Health and Human Services, Bethesda, MD. NHLBI NAEP Publication No. 92-3091.
3. International Consensus Report of Diagnosis and Treatment of Asthma. 1992. NHLBI NIH Publication No. 92-3091.
4. British Thoracic Society. Guidelines on the management of asthma. 1993. Thorax 48:S1-S24.
5. Douglas, J. G., P. Rafferty, R. J. Fergusson, R. J. Prescott, G. K. Crompton, and I. W. B. Grant. 1985. Nebulized salbutamol without oxygen in severe acute asthma: how effective and how safe? Thorax 40:180-183.
6. Robertson, C. F., F. Smith, R. Beck, and H. Levison. 1985. Response to frequent low doses of nebulized salbutamol in acute asthma. J. Pediatr. 106:672-674.
7. Shapiro, G. G., C. T. Furukawa, W. E. Pierson, M. K. Chapko, M. Sharpe, and C. W. Bierman. 1987. Double-blind, dose-response study of metaproterenol inhalant solution in children with acute asthma. J. Allergy Clin. Immunol. 79:378-386.
8. Schuh, S., P. Parkin, A. Rajan, G. Canny, R. Healy, M. Rieder, Y. K. Tan, H. Levison, and S. J. Soldin. 1989. High- versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics 83:513-518.
9. Schuh, S., M. J. Reider, G. Canny, E. Pender, T. Forbes, Y. K. Tan, D. Bailey, and H. Levison. 1990. Nebulized Albuterol in acute childhood asthma: comparison of two doses. Pediatrics 86:509-513.
10. Nelson, M. S., A. Hofstadter, J. Parker, and C. Hargis. 1990. Frequency of inhaled Metaproterenol in the treatment of acute asthma exacerbation. Ann. Emerg. Med. 19:21-25.
11. Appel, D., J. P. Karpel, and M. Sherman. 1989. Epinephrine improves expiratory flow rates in patients with asthma who do not respond to inhaled metaproterenol sulfate. J. Allergy Clin. Immunol. 84:90-98.
12. Weiss, K. B., P. J. Gergen, and T. A. Hodgson. 1992. An economic evaluation of asthma in the United States, N. Engl. J. Med. 326:862-866.
13. McFadden, E. R., Jr., N. Elsanadi, L. Dixon, M. Tackacs, E. C. Deal, K. K. Boyd, B. K. Idemoto, L. A. Broseman, J. Panuska, T. Hammons, B. Smith, F. Caruso, C. B. McFadden, L. Shoemaker, E. L. Warren, R. Hejal, L. Strauss, and I. Gilbert. 1995. Protocol therapy for acute asthma: therapeutic benefits and cost savings. Am. J. Med. 99:651-661.
14. Leiner, G. C., S. Abramowitz, M. Mall, V. Stenby, and W. Lewis. 1963. Expiratory peak flow rate. Standard values for normal subjects. Use as a clinical test of ventilatory function. Am. Rev. Respir. Dis. 88: 644-651.
15. Lewis, J. E., W. Richards, J. A. Church, A. Haftel, and T. G. Keens. 1985. Therapy of acute asthma: I. Evaluation of successive bronchodilator treatments. Ann. Allergy 55:472-475.
16. Rossing, T. H., C. H. Fanta, D. H. Goldstein, J. Snapper, Jr., and E. R. McFadden, Jr. 1980. Emergency therapy of asthma: comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline. Am. Rev. Respir. Dis. 122:365-371.
17. Rossing, T. H., C. H. Fanta, and E. R. McFadden, Jr. 1981. A controlled trial of the use of single versus combined drug therapy in the treatment of acute episodes of asthma. Am. Rev. Respir. Dis. 123: 190-194.
18. Fanta, C. H., R. H. Rossing, and E. R. McFadden, Jr. 1982. Emergency room treatment of asthma: relationships among therapeutic combinations, severity of obstruction and the time course of response. Am. J. Med. 72:416-422.
19. Colacone, A., M. Afilalo, N. Wokove, and H. Kreisman. 1993. A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. Chest 104:835-841.
20. Britton, J., and A. Tattersfield. 1984. Comparison of cumulative and non-cumulative techniques to measure dose-response curves for beta agonists in patients with asthma. Thorax 39:597-599.
21. Rossing, T. H., C. H. Fanta, and E. R. McFadden, Jr. 1983. Effect of self-treatment of asthma with beta agonists on the response to sympathomimetics in an emergency room. Am. J. Med. 75:781-784.
22. Alvin, G. F., P. Rodgers, K. M. Fitzsimmons, and R. C. Ahrens. 1992. Disposable jet nebulizers: how reliable are they? Chest 101:316-319.
23. Idris, A. H., M. F. McDermott, J. C. Raucci, A. Morrabel, and S. McGorray. 1993. Emergency department treatment of severe asthma: metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest 103:665-672.
24. Fischl, M. A., A. Pitchenik, and L. B. Gardner. 1981. An index predicting relapse and need for hospitalization in patients with acute bronchial asthma. N. Engl. J. Med. 305:783-789.
25. Rose, C., G. Murphy, and J. S. Schwartz. 1984. Performance of an index predicting the response of patients with acute bronchial asthma to intensive emergency department treatment. N. Engl. J. Med. 310: 573-576.
26. Centor, R. M., B. Yarbrough, and P. Wood. 1984. Inability to predict relapse in acute asthma. N. Engl. J. Med. 310:577-580.
27. McFadden, E. R., Jr., R. Kiser, and W. J. DeGroot. 1973. Acute bronchial asthma: relations between clinical and physiologic manifestations. N. Engl. J. Med. 288:221-225.